Table III.
Effects of Diuretics on Cholesterol Levels in Controlled Clinical Trials
Berglund & Anderson | |
6 Yr | −12 |
MRC Trial | |
3 + Yr | |
Men/Women—Rx/Pl | 0/‐1/‐5–4 |
MAPHY | |
6 Yr | −1 |
HDFP | |
4 Yr (SI) | |
High doses diuretics | −9 |
Oslo | |
4 Yr | |
Active Rx/control | +1/+2 |
MRFIT | |
6 Yr | |
(SI) (UC) | −18/−14 |
MRC=Medical Research Council study; MAPHY=Metoprolol Atherosclerosis Prevention in Hypertension; HDFP=Hypertension Detection and Follow‐up Program; MRFIT=Multiple Risk Factor Intervention Trial; Pl=placebo; C=care; SI=special intervention; UC=usual care |